Table 2.

TIAs and CITS in the territory of the stented after 30 days

Patient Number	Age at Enrollment (yrs)	Gender	Symptomatic Artery	Adjudicated Event	Months After Enrollment	ISR Status (Modality)	Anti- Platelet Rx Post Event	Months of Follow-up After CITS/TIA	Subsequent Events (Time after Initial Adjudicated Event)
1	65.0	Female	MCA stem (M1)	CITS	4.0	ISR (DSA)	DAPT	34.7	TIA (8.5 months)
2	53.2	Male	Basilar	CITS	11.2	No ISR (DSA)		15.7	.
3	70.7	Male	MCA stem (M1)	CITS	4.9	ISR (DSA)	DAPT	26.6	.
4	62.9	Female	MCA stem (M1)	CITS	4.8	ISR (DSA)	DAPT	23.1	CITS (1.0 month)
5	65.2	Male	Vertebral	CITS	27.5	No ISR (DSA)		19.6	.
6	48.8	Female	MCA stem (M1)	CITS	3.6	ISR (MRA)	Aspirin	5.5	.
7	56.2	Male	MCA stem (M1)	CITS	9.9	Indeterminate (CTA)		20.9	.
8	61.0	Male	Vertebral	CITS	1.4	ISR (CTA)	DAPT	45.5	.
9	48.7	Female	Basilar	CITS	3.5	No Imaging		27.4	TIA (4.2 months)
10	69.8	Female	MCA stem (M1)	CITS	3.4	No ISR (DSA)		38.8	.
11	59.3	Male	Intracranial carotid	TIA	4.8	ISR (DSA)	Aspirin	24	TIA (12.3 months)
12	53.6	Female	Intracranial carotid	TIA	3.5	No Imaging		24.9	.
13	32.9	Female	MCA stem (M1)	TIA	7.3	ISR (DSA)	Aspirin	36.4	TIA (8 days)
14	53.4	Male	MCA stem (M1)	TIA	24.3	ISR (DSA)	Aspirin	17.8	.
15	68.1	Male	Intracranial carotid	TIA	25.8	ISR (DSA)	DAPT	18.3	CITS (2.3 months)
16	45.5	Male	MCA stem (M1)	TIA	35.9	No Imaging		12.1	.
17	44.4	Male	Basilar	TIA	3.0	ISR (CTA)	Aspirin	45.3	TIA × 3 (2 days, 4.6 months, 13.1 months)
18	72.7	Male	Basilar	TIA	12.5	No ISR (CTA)		24.4	.
19	56.9	Male	Vertebral	TIA	9.6	No Imaging		29.2	.
20	72.7	Female	MCA stem (M1)	TIA	6.0	No Imaging		19.7	.
21	51.1	Male	Vertebral	TIA	6.1	No Imaging		39.4	.
22	60.0	Female	Intracranial carotid	TIA	4.6	No Imaging		23.2	.
23	35.8	Male	MCA stem (M1)	TIA	3.5	No ISR (MRA)		28.5	.
24	49.8	Female	MCA stem (M1)	TIA	9.8	ISR (DSA)	DAPT	17	.
25	59.8	Female	Basilar	TIA	18.0	ISR (DSA)	DAPT	27.3	Angioplasty at 18 months
26	59.4	Male	Basilar	TIA	11.7	ISR (DSA)	DAPT	22.7	.

DAPT = Dual antiplatelet